These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30797568)

  • 1. Pharmacoepidemiology in pregnancy.
    Benevent J; Araujo M; Hurault-Delarue C; Montastruc JL; Sommet A; Lacroix I; Damase-Michel C
    Therapie; 2019 Apr; 74(2):289-300. PubMed ID: 30797568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of pharmacoepidemiology in pregnancy-implications for safety.
    Benevent J; Montastruc F; Damase-Michel C
    Expert Opin Drug Saf; 2017 Oct; 16(10):1181-1190. PubMed ID: 28777918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?
    Hurault-Delarue C; Chouquet C; Savy N; Lacroix I; Beau AB; Montastruc JL; Damase-Michel C
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):770-7. PubMed ID: 27018245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP).
    Davis RL
    J Popul Ther Clin Pharmacol; 2010; 17(3):e336-40. PubMed ID: 21041866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MIHARI project: establishing a new framework for pharmacoepidemiological drug safety assessments by the Pharmaceuticals and Medical Devices Agency of Japan.
    Ishiguro C; Takeuchi Y; Uyama Y; Tawaragi T
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):854-9. PubMed ID: 27222073
    [No Abstract]   [Full Text] [Related]  

  • 6. [The double death of drug surveillance].
    Bégaud B
    Assist Inferm Ric; 2019; 38(1):31-35. PubMed ID: 30933189
    [No Abstract]   [Full Text] [Related]  

  • 7. Methods in pharmacoepidemiology.
    Sommet A; Pariente A
    Therapie; 2019 Apr; 74(2):187-197. PubMed ID: 30819408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion of pregnant and breastfeeding women in research - efforts and initiatives.
    Illamola SM; Bucci-Rechtweg C; Costantine MM; Tsilou E; Sherwin CM; Zajicek A
    Br J Clin Pharmacol; 2018 Feb; 84(2):215-222. PubMed ID: 28925019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoepidemiological research for the development and evaluation of drugs in pediatrics.
    Kaguelidou F; Durrieu G; Clavenna A
    Therapie; 2019 Apr; 74(2):315-324. PubMed ID: 30773345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is pharmacoepidemiology? Definition, methods, interest and clinical applications.
    Montastruc JL; Benevent J; Montastruc F; Bagheri H; Despas F; Lapeyre-Mestre M; Sommet A
    Therapie; 2019 Apr; 74(2):169-174. PubMed ID: 30389102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication Exposure in Pregnancy Risk Evaluation Program.
    Andrade SE; Davis RL; Cheetham TC; Cooper WO; Li DK; Amini T; Beaton SJ; Dublin S; Hammad TA; Pawloski PA; Raebel MA; Smith DH; Staffa JA; Toh S; Dashevsky I; Haffenreffer K; Lane K; Platt R; Scott PE
    Matern Child Health J; 2012 Oct; 16(7):1349-54. PubMed ID: 22002179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review on the application of pharmacoepidemiology in assessing prescription drug-related adverse events in pediatrics.
    Luo X; Cappelleri JC; Frush K
    Curr Med Res Opin; 2007 May; 23(5):1015-24. PubMed ID: 17526119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interest of pharmacoepidemiology for the study of inhaled drugs.
    Molimard M; Girodet PO; Van Ganse E
    Therapie; 2019 Apr; 74(2):233-237. PubMed ID: 30392699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immortal time bias in pharmacoepidemiological studies: definition, solutions and examples].
    Faillie JL; Suissa S
    Therapie; 2015; 70(3):259-63. PubMed ID: 25487848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoepidemiological safety studies in children: a systematic review.
    Osokogu OU; Dukanovic J; Ferrajolo C; Dodd C; Pacurariu AC; Bramer WM; 'tJong G; Weibel D; Sturkenboom MC; Kaguelidou F
    Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):861-70. PubMed ID: 27255559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a mother-child database for drug exposure and adverse event detection in the Military Health System.
    Taylor LG; Thelus Jean R; Gordon G; Fram D; Coster T
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):510-7. PubMed ID: 25833769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: harmonization in pharmacoepidemiological studies: (twi)light at the end of the tunnel?
    Mangoni AA
    Curr Clin Pharmacol; 2014 May; 9(2):91-2. PubMed ID: 24702185
    [No Abstract]   [Full Text] [Related]  

  • 18. Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.
    Pottegård A; Friis S; Stürmer T; Hallas J; Bahmanyar S
    Basic Clin Pharmacol Toxicol; 2018 May; 122(5):451-459. PubMed ID: 29265740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoepidemiology research: delivering evidence about drug safety and effectiveness in mental health.
    Davis KAS; Farooq S; Hayes JF; John A; Lee W; MacCabe JH; McIntosh A; Osborn DPJ; Stewart RJ; Woelbert E
    Lancet Psychiatry; 2020 Apr; 7(4):363-370. PubMed ID: 31780306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoepidemiology in older people: Purposes and future directions.
    Laroche ML; Sirois C; Reeve E; Gnjidic D; Morin L
    Therapie; 2019 Apr; 74(2):325-332. PubMed ID: 30773343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.